Teva and Trump Administration pledge lower Medicaid medicine costs
Teva said it shares a commitment with the Trump Administration to lower the cost of select medicines for American patients covered by Medicaid, aiming to expand access and affordability. The company also offered a dedicated reserve of certain active pharmaceutical ingredients to support public health needs and continued investment in the U.S.